Intellectual Property

Patent pending technology to treat chronic pain and promote neurological rehabilitation.

Health Canada’s License

Licensed laboratory in Toronto approved for possession, production and assembling of scheduled drugs.

Data Collection

Completed research at Queen’s University investigating for chronic pain, depression, musculoskeletal disorders and the alteration of sensory perception.

Development Pipeline

  • Grant funded research study at Queen’s University complete

  • Initial clinical data to be submitted to FDA for Breakthrough Therapy to expedite development of novel technology